The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion - reperfusion injury

被引:1
|
作者
Ge, Chaowen [1 ,2 ,3 ]
Meng, Dongdong [1 ,2 ,3 ]
Peng, Yuqin [1 ,2 ,3 ]
Huang, Ping [1 ,2 ]
Wang, Ning [1 ,2 ]
Zhou, Xian [4 ]
Chang, Dennis [4 ]
机构
[1] Anhui Univ Chinese Med, Anhui Prov Key Lab Res & Dev Chinese Med, Hefei 230012, Peoples R China
[2] Anhui Univ Chinese Med, Anhui Prov Key Lab Chinese Med Formula, Hefei 230012, Peoples R China
[3] Anhui Acad Tradit Chinese Med, Inst Pharmacodynam & Safety Evaluat Chinese Med, Hefei 230012, Peoples R China
[4] Western Sydney Univ, NICM Hlth Res Inst, Sydney, NSW, Australia
关键词
Hydroxysafflor yellow A; Myocardial ischemia/reperfusion injury; Angiogenesis; HIF-1; alpha-VEGFA-Notch1; CELL APOPTOSIS;
D O I
10.1016/j.intimp.2024.113097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hydroxyl Safflower Yellow A (HSYA) is the primary bioactive compound derived from Safflower, which has been scientifically proven to possess anti-inflammatory, anti-apoptotic, and ameliorative properties against mitochondrial damage during acute myocardial ischemia-reperfusion injury (MIRI); however, its effects during the recovery stage remain unknown. Angiogenesis plays a crucial role in the rehabilitation process. Aim of the study: The objective of this study was to investigate the long-term angiogenic effect of HSYA and its contribution to recovery after myocardial ischemia, as well as explore its underlying mechanism using non- targeted metabolomics and network pharmacology. Materials and methods: The MIRI model in rat was established by ligating the left anterior descending branch of the coronary artery. The effect of HSYA was assessed based on myocardial infarction volume and histopathology. Immunofluorescence staining was employed to evaluate angiogenesis, while ELISA was used to detect markers of myocardial injury. Additionally, a rat myocardial microvascular endothelial cell (CMECs) injury model was established using oxygen-glucose deprivation/reoxygenation (OGD/R), followed by scratch assays, migration assays, and tube formation experiments to assess angiogenesis. Western blot analysis was conducted to validate the underlying mechanism.<br /> Results: Our findings provide compelling evidence for the therapeutic efficacy of HSYA in reducing myocardial infarction size, facilitating cardiac functional recovery, and reversing pathological alterations within the heart. Furthermore, we elucidate that HSYA exerts its effects on promoting migration and generation of myocardial microvascular endothelial cells through activation of the HIF-1 alpha-VEGFA-Notch1 signaling pathway. Conclusion. These results underscore how HSYA enhances cardiac function via angiogenesis promotion and activation of the aforementioned signaling cascade.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] HIF-1α in myocardial ischemia-reperfusion injury
    Zheng, Jie
    Chen, Peier
    Zhong, Jianfeng
    Cheng, Yu
    Chen, Hao
    He, Yuan
    Chen, Can
    MOLECULAR MEDICINE REPORTS, 2021, 23 (05)
  • [2] Dan-Deng-Tong-Nao softgel capsule promotes angiogenesis of cerebral microvasculature to protect cerebral ischemia reperfusion injury via activating HIF-1α-VEGFA-Notch1 signaling pathway
    Wang, Lei
    Li, Jiacheng
    Wang, Yang
    Ge, Chaowen
    Huang, Qi
    Li, Lili
    Wang, Ning
    Chen, Yuang
    Zhou, Xian
    Chang, Dennis
    Li, Dan
    Hou, Jincai
    PHYTOMEDICINE, 2023, 118
  • [3] Levosimendan reduces myocardial ischemia-reperfusion injury by regulating the expression of HIF-1α
    Chen, Jinyou
    Gao, Yue
    Wang, Xiaonan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (11): : 8592 - 8598
  • [4] Mitigation of myocardial ischemia-reperfusion injury via HIF-1α-frataxin signaling
    Amaral, Nelson
    Okonko, Darlington O.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (05): : H728 - H730
  • [5] Cardioprotective HIF-1α-frataxin signaling against ischemia-reperfusion injury
    Nanayakkara, Gayani
    Alasmari, Abdullah
    Mouli, Shravanthi
    Eldoumani, Haitham
    Quindry, John
    McGinnis, Graham
    Fu, Xiaoyu
    Berlin, Avery
    Peters, Bridget
    Zhong, Juming
    Amin, Rajesh
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (05): : H867 - H879
  • [6] HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
    Si, Jingwen
    Wang, Ning
    Wang, Huan
    Xie, Juan
    Yang, Jian
    Yi, Hui
    Shi, Zixuan
    Ma, Jing
    Wang, Wen
    Yang, Lifang
    Yu, Shigiang
    Li, Junchang
    PLOS ONE, 2014, 9 (09):
  • [7] Cardamonin attenuates cerebral ischemia/reperfusion injury by activating the HIF-1 alpha/VEGFA pathway
    Ni, Hongzao
    Li, Jinxiao
    Zheng, Jinyu
    Zhou, Botao
    PHYTOTHERAPY RESEARCH, 2022, 36 (04) : 1736 - 1747
  • [8] Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway
    Ge, Chaowen
    Peng, Yuqin
    Li, Jiacheng
    Wang, Lei
    Zhu, Xiaoyu
    Wang, Ning
    Yang, Dongmei
    Zhou, Xian
    Chang, Dennis
    NUTRIENTS, 2023, 15 (15)
  • [9] α-Mangostin protects against myocardial ischemia reperfusion injury by suppressing the activation of HIF-1α
    Jiang, Hong
    Guo, Wenli
    Zhu, Dongdong
    Zhang, Wei
    Yu, Jing
    Feng, Manli
    Wang, Xiaoyu
    Wang, Xiaopeng
    Jiao, Yanan
    Wang, Chengcheng
    Chen, Yan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (01) : 25 - 31
  • [10] DEXMEDETOMIDINE AMELIORATES ACUTE BRAIN INJURY INDUCED BY MYOCARDIAL ISCHEMIA-REPERFUSION VIA UPREGULATING THE HIF-1 PATHWAY
    Yang, Xue
    Wu, Jianjiang
    Cheng, Hu
    Chen, Siyu
    Wang, Jiang
    SHOCK, 2023, 60 (05): : 678 - 687